0001209191-21-049120.txt : 20210802 0001209191-21-049120.hdr.sgml : 20210802 20210802184911 ACCESSION NUMBER: 0001209191-21-049120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210729 FILED AS OF DATE: 20210802 DATE AS OF CHANGE: 20210802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siegel Jolie CENTRAL INDEX KEY: 0001768223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39567 FILM NUMBER: 211137320 MAIL ADDRESS: STREET 1: C/O NEON THERAPEUTICS, INC. STREET 2: 40 ERIE ST., SUITE 110 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: C4 Therapeutics, Inc. CENTRAL INDEX KEY: 0001662579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475617627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 231-0700 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-29 0 0001662579 C4 Therapeutics, Inc. CCCC 0001768223 Siegel Jolie C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #200 WATERTOWN MA 02472 0 1 0 0 Chief Legal Officer Common Stock 2021-07-29 4 M 0 12500 4.98 A 12500 D Common Stock 2021-07-29 4 S 0 12500 45.00 D 0 D Stock Option (Right to Buy) 4.98 2021-07-29 4 M 0 12500 0.00 D 2030-07-02 Common Stock 12500 283821 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. 20% of this option vested and became exercisable on July 1, 2021, with the remainder vesting in 16 equal quarterly installments thereafter. /s/ Shoaib Ghias, Attorney-in-Fact 2021-08-02